Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect

International Journal of Antimicrobial Agents

Volumn 34, Issue SUPPL. 1, 2009, Pages S8-

  Gould, Ian M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotics; Diagnosis; Meticillin resistant Staphylococcus aureus; Pathogenesis; Primary prevention; Skin and soft tissue infections

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; MACROLIDE; PANTON VALENTINE LEUKOCIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BACTERIUM CULTURE; DRUG EXPOSURE; DRUG USE; GENE CASSETTE; HAND WASHING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL DRAINAGE; UNITED STATES; ZOONOSIS;

EID: 67649210231     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(09)70542-4     Document Type: Article

References (34)

1. Gould I.M. The two Alexanders (Gordon and Ogston): Aberdeen's early contribution to the understanding of infection control. Int J Antimicrob Agents 32 (2008) 467
2. Isbister C., Durie E.B., Rountree P.M., and Freeman B.M. Further study of staphylococcal infection of the new-born. Med J Aust 2 (1954) 897-900
3. An Diep B., and Otto M. The role of virulence determinants in community associated MRSA pathogenesis. Trends Microbiol 16 (2008) 361-369
4. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
5. Tong S., McDonald M.I., Holt D.C., and Currie B.J. Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in indigenous populations. Clin Infect Dis 46 (2008) 1871-1878
6. Lindsay J.A., and Holden M.T. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics 6 (2006) 186-201
7. Badiou C., Dumitrescu O., Croze M., Gillet Y., Dohin B., Slayman D.H., et al. Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect 14 (2008) 1180-1183
8. Gould IM, Girvan K, Browning RA, MacKenzie FM, Edwards G. Report of a hospital neonatal unit outbreak of community acquired methicillin resistant Staphylococcus aureus. Epidemiol Infect. Epub 2009 Mar 10.
9. El Helali N., Carbonne A., Naas T., Kerneis S., Fresco O., Giovangrandi Y., et al. Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control. J Hosp Infect 61 (2005) 130-138
10. Jernigan J.A., Clemence M.A., Stott G.A., Titus M.G., Alexander C.H., and Palumbo C.M. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 16 (1995) 686-696
11. Huang S.S., and Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36 (2003) 281-285
12. Miller L.G., and An D. B. Colonization, fomites and virulence: Rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46 (2008) 752-760
13. An Diep B., Chambers F., Graber C.J., Szumowski J.D., Miller L.G., and Han L.L. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus Clone USA300 in men who have sex with men. Ann Intern Med 148 (2008) 249-257
14. Gould I.M. Antibiotic policies to control hospital-acquired infection. J Antimicrob Chemother 61 (2008) 763-765
15. David M.Z., Mennella C., Mansour M., Boyle-Vavra S., and Daum R.S. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. J Clin Microbiol 46 (2008) 3222-3227
16. Tong S.Y., McDonald M.I., Holt D.C., and Currie B.J. Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in indigenous populations. Clin Infect Dis 46 (2008) 1871-1878
17. Wootton S.H., Arnold K., Hill H.A., McAllister S., Ray M., Kellum M., et al. Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infect Control Hosp Epidemiol 25 (2004) 402-407
18. Cheng V.C., Li I.W., Wu A.K., Tang B.S., Ng K.H., To K.K., et al. Effectofantibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonization in anterior nares. J Hosp Infect 70 (2008) 27-34
19. Dancer S.J. The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 61 (2008) 246-253
20. Kunori T., Cookson B., Roberts J.A., Stone S., and Kibbler C. Cost effectiveness of different MRSA screening methods. J Hosp Infect 51 (2002) 189-200
21. Francois P., Bento M., Renzi G., Harbarth S., Pittet D., and Schrenzel J. Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45 (2007) 2011-2013
22. Currie A., Davis L., Odrobina E., Waldman S., White D., Tomassi J., et al. Sensitivities of nasal and rectal swabs for detection of methicillin-resistant Staphylococcus aureus colonization in an active surveillance program. J Clin Microbiol 46 (2008) 3101-3103
23. Zafar U., Johnson L.B., Hanna M., Riederer K., Sharma M., Fakih M.G., et al. Prevalence of nasal colonization among patients with communityassociated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infect Control Hosp Epidemiol 28 (2007) 966-969
24. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367 (2006) 731-739
25. Proctor R.A. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46 (2008) 584-593
26. Gould I.M. MRSA bacteraemia. Int J Antimicrob Agents 30 (2007) 66-70
27. Fowler Jr. V.G., Boucher H.W., Corey G.R., Abrutyn E., Karchmer A.W., and Rupp M.E. Daptomycin versus standard therapy for bacteraemia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355 (2006) 653-665
28. Gould I.M. The problem with glycopeptides. Int J Antimicrob Agents 30 (2007) 1-3
29. Wilcox M.H., Tack K.J., Bouza E., Herr D.L., Ruf B.R., Ijzerman M.M., et al. Compli-cated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis 48 (2009) 203-212
30. Florescu I., Beuran M., Dimov R., Razbadauskas A., Bochan M., Fichev G., et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother 62 (2008) 17-28
31. Sandiumenge A., Diaz E., Rodriguez A., Vidaur L., Canadell L., Olona M., et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 57 (2006) 1197-1204
32. Prevention of MRSA spreading: guidelines (2008), National Board of Health, Copenhagen. http://www.sst.dk/publ/publ2008/CFF/MRSA/MRSA_vejl_en_19mar08.pdf [accessed 20 March 2009].
33. Gould I.M. Community-acquired MRSA: can we control it?. Lancet 368 (2006) 824-826
34. Stepanovic S., Dimitrijevic V., Vukovic D., Dakic I., Savic B., and Svavic Vlahovic M. Staphylococcus sciuri as part of skin, nasal and oral flora in healthy dogs. Vet Microbiol 82 (2001) 177-185